• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 5. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509

Professional Introduction to 2-(Quinolin-6-yl)propanoic acid (CAS No. 959585-30-9)

2-(Quinolin-6-yl)propanoic acid, identified by its Chemical Abstracts Service (CAS) number 959585-30-9, is a significant compound in the field of chemical and biomedical research. This compound has garnered attention due to its unique structural properties and potential applications in drug discovery and therapeutic development. The quinoline moiety, a well-known pharmacophore, contributes to the compound's biological activity, making it a valuable scaffold for designing novel pharmaceutical agents.

The molecular structure of 2-(Quinolin-6-yl)propanoic acid consists of a propionic acid side chain attached to a quinoline ring at the 6-position. This configuration allows for diverse interactions with biological targets, which is crucial for developing effective therapeutic interventions. The quinoline ring is particularly noteworthy for its presence in numerous bioactive molecules, including antimalarial and anticancer agents. The combination of the quinoline moiety with the propanoic acid group creates a versatile platform for further chemical modifications, enabling the synthesis of derivatives with enhanced pharmacological properties.

In recent years, there has been a surge in research focused on quinoline derivatives due to their broad spectrum of biological activities. Studies have demonstrated that compounds containing the quinoline scaffold exhibit potent effects on various biological pathways, including enzyme inhibition and receptor binding. For instance, recent investigations have highlighted the potential of quinoline-based molecules in targeting kinases and other enzymes involved in cancer progression. 2-(Quinolin-6-yl)propanoic acid has been explored as a precursor in the synthesis of such derivatives, offering a promising route to develop novel anticancer agents.

The propanoic acid moiety in 2-(Quinolin-6-yl)propanoic acid provides an additional site for functionalization, allowing researchers to tailor the compound's properties for specific applications. This flexibility has been exploited in the design of prodrugs and targeted delivery systems, where the propanoic acid group can be modified to enhance solubility or improve tissue penetration. Such modifications are critical for optimizing drug bioavailability and therapeutic efficacy.

Moreover, the compound's structural features make it an attractive candidate for use in computational modeling and virtual screening. Advanced computational techniques have been employed to predict the binding affinity of 2-(Quinolin-6-yl)propanoic acid and its derivatives to various biological targets. These studies have provided valuable insights into the compound's mechanism of action and have guided the design of more potent and selective pharmacological agents.

The synthesis of 2-(Quinolin-6-yl)propanoic acid involves multi-step organic reactions that require precise control over reaction conditions. Recent advancements in synthetic methodologies have enabled more efficient and scalable production of this compound. For example, catalytic asymmetric synthesis has been utilized to introduce chirality into the molecule, which is essential for developing enantiomerically pure pharmaceuticals with improved pharmacokinetic profiles.

In conclusion, 2-(Quinolin-6-yl)propanoic acid (CAS No. 959585-30-9) represents a significant advancement in chemical and biomedical research. Its unique structural features and potential applications in drug discovery make it a valuable compound for further investigation. As research continues to uncover new therapeutic targets and develop innovative synthetic strategies, compounds like 2-(Quinolin-6-yl)propanoic acid are poised to play a crucial role in the development of next-generation pharmaceuticals.

• 1537784-56-7(2-(1H-indol-5-yl)propanoic acid)
• 1539775-73-9(2-(quinolin-4-yl)propanoic acid)
• 1871539-72-8(2-Methyl-2-(quinolin-4-yl)propanoic acid)
• 1022283-51-7(2-Methyl-2-(quinolin-6-YL)propanoic acid)
• 1247842-46-1(2-(Quinolin-3-yl)propanoic acid)
• 52263-68-0(2-(9H-Carbazol-2-yl)propanoic acid)
• 2248186-22-1((2R)-2-Quinolin-6-ylpropanoic acid)
• 1500548-32-2(2-(Quinolin-7-yl)propanoic acid)
• 581813-22-1(2-(Isoquinolin-5-yl)propanoic acid)
• 2248199-35-9((2R)-2-Isoquinolin-6-ylpropanoic acid)